WNT3A and hepatocellular carcinoma: Plain-AuNPs i.p. and DOX groups significantly decreased hepatic Wnt-3a level by 22.11% (p < 0.001) and 57.17% (p < 0.001) than HCC group, while DOX-AuNPs significantly decreased Wnt-3a level by 69.2% (p < 0.001) compared to HCC, and by 28.08% (p < 0.01) compared to DOX.